基金经理：马君
| 单位净值:0.7045 | 净值增长率:-2.13% | 净值增长率:-2.13% | 累计净值:1.4090 | 截止日期:2026/9/9 | |
|---|---|---|---|---|---|
| 最新估值:-(-) | 涨跌幅:- | 涨跌额:- | |||
| 最新规模:75.27亿元 | 风险等级:高风险 | 申购状态:可申购 | 赎回状态:可赎回 |
展开全部
- 基本资料
- 投资风格
- 基金财务状况
- 基金评级
港股创新药ETF(159567)申购赎回 |
||||||
|---|---|---|---|---|---|---|
| 报告期 | 期初总份额(份) | 期末总份额(份) | 期间总申购份额(份) | 期间总赎回份额(份) | 期间净申赎份额(份) | 净申赎比例 |
| 2026/6/30 | 10,491,700,000 | 10,684,700,000 | 4,612,000,000 | 4,419,000,000 | 193,000,000 | 1.84% |
| 2026/6/30 | 10,067,700,000 | 10,684,700,000 | 3,852,000,000 | 3,235,000,000 | 617,000,000 | 6.13% |
| 2026/3/31 | 10,491,700,000 | 10,067,700,000 | 760,000,000 | 1,184,000,000 | -424,000,000 | -4.04% |
| 2025/12/31 | 395,365,000 | 10,491,700,000 | 8,477,000,000 | 1,066,000,000 | 7,411,000,000 | 1874.47% |
| 2025/12/31 | 8,142,730,000 | 10,491,700,000 | 2,612,000,000 | 263,000,000 | 2,349,000,000 | 28.85% |
| 2025/9/30 | 1,806,360,000 | 8,142,730,000 | 4,110,000,000 | 459,000,000 | 3,651,000,000 | 202.12% |
| 2025/6/30 | 395,365,000 | 1,806,360,000 | 1,755,000,000 | 344,000,000 | 1,411,000,000 | 356.89% |
| 2025/6/30 | 574,365,000 | 1,806,360,000 | 1,540,000,000 | 308,000,000 | 1,232,000,000 | 214.5% |
| 2025/3/31 | 395,365,000 | 574,365,000 | 215,000,000 | 36,000,000 | 179,000,000 | 45.27% |
| 2024/12/31 | 236,365,000 | 395,365,000 | 490,000,000 | 331,000,000 | 159,000,000 | 67.27% |
| 2024/12/31 | 195,365,000 | 395,365,000 | 272,000,000 | 72,000,000 | 200,000,000 | 102.37% |
| 2024/9/30 | 171,365,000 | 195,365,000 | 78,000,000 | 54,000,000 | 24,000,000 | 14.01% |
| 2024/6/30 | 236,365,000 | 171,365,000 | 140,000,000 | 205,000,000 | -65,000,000 | -27.5% |
| 2024/6/30 | 165,365,000 | 171,365,000 | 51,000,000 | 45,000,000 | 6,000,000 | 3.63% |
| 2024/3/31 | 236,365,000 | 165,365,000 | 89,000,000 | 160,000,000 | -71,000,000 | -30.04% |
*注：新浪财经提醒：以上数据由合作伙伴提供，仅供参考，交易请以正式公告数据为准。